#Brain Science (3)
-
Multiple Myeloma and Cognitive Impairment: Treatment Effects, Chemo-Fog & Clinical Findings — Evidence Review
Up to 30% of multiple myeloma patients report cognitive decline during the first six months of treatment, though objective evidence remains limited.
-
Gut Microbiome and Mental Health: What the Science Really Shows
Your gut bacteria produce neurotransmitters and communicate with your brain—and emerging evidence links microbial imbalances to anxiety and depression.
-
GLP-1 for Appetite and Cravings: How Semaglutide & Tirzepatide Work (Evidence Review)
GLP-1 drugs suppress appetite through brain pathways that control reward and satiety—effects extending beyond blood sugar to food cravings, gastric emptying, and even addictive behaviors.